Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis
CompletedOBSERVATIONAL
Enrollment
76
Participants
Timeline
Start Date
December 31, 2007
Study Completion Date
November 30, 2008
Conditions
Hematologic DiseasesSepsis
Trial Locations (1)
38043
University Hospital of Grenoble, Grenoble
All Listed Sponsors
lead
University Hospital, Grenoble
OTHER
NCT00561639 - Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis | Biotech Hunter | Biotech Hunter